My Cancer Genome contains information on the clinical impact of molecular biomarkers in cancer-related genes, proteins, and other biomarker types on the use of anticancer therapies in cancer. This information is derived from FDA labels, NCCN and other professional society guidelines, clinical trials, peer-reviewed publications, and more.
Learn About My Cancer Genome